BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34435047)

  • 1. The Role of Respiratory Flora in the Pathogenesis of Chronic Respiratory Diseases.
    Guo MY; Chen HK; Ying HZ; Qiu FS; Wu JQ
    Biomed Res Int; 2021; 2021():6431862. PubMed ID: 34435047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.
    Magryś A
    Pol J Microbiol; 2021 Mar; 70(1):25-32. PubMed ID: 33815524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.
    Mendez R; Banerjee S; Bhattacharya SK; Banerjee S
    IUBMB Life; 2019 Feb; 71(2):152-165. PubMed ID: 30466159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of the microbiota in chronic respiratory disease.
    Budden KF; Shukla SD; Rehman SF; Bowerman KL; Keely S; Hugenholtz P; Armstrong-James DPH; Adcock IM; Chotirmall SH; Chung KF; Hansbro PM
    Lancet Respir Med; 2019 Oct; 7(10):907-920. PubMed ID: 30975495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Human Respiratory Microbiome: Current Understandings and Future Directions.
    Zhao L; Luo JL; Ali MK; Spiekerkoetter E; Nicolls MR
    Am J Respir Cell Mol Biol; 2023 Mar; 68(3):245-255. PubMed ID: 36476129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease.
    Caverly LJ; Huang YJ; Sze MA
    Chest; 2019 Aug; 156(2):376-382. PubMed ID: 31154042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
    Ghosh A; Saha S
    J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
    [No Abstract]   [Full Text] [Related]  

  • 9. The microbiome in respiratory medicine: current challenges and future perspectives.
    Faner R; Sibila O; Agustí A; Bernasconi E; Chalmers JD; Huffnagle GB; Manichanh C; Molyneaux PL; Paredes R; Pérez Brocal V; Ponomarenko J; Sethi S; Dorca J; Monsó E
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-microbe interactions in distal airways: relevance to chronic airway diseases.
    Martin C; Burgel PR; Lepage P; Andréjak C; de Blic J; Bourdin A; Brouard J; Chanez P; Dalphin JC; Deslée G; Deschildre A; Gosset P; Touqui L; Dusser D
    Eur Respir Rev; 2015 Mar; 24(135):78-91. PubMed ID: 25726559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anaerobic bacteria, the unknown members of the lung microbiota].
    Guilloux CA; Lamoureux C; Héry-Arnaud G
    Med Sci (Paris); 2018 Mar; 34(3):253-260. PubMed ID: 29547112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterising the respiratory microbiome.
    Watson RL; de Koff EM; Bogaert D
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30487204
    [No Abstract]   [Full Text] [Related]  

  • 14. Respiratory Viral Infections in Chronic Lung Diseases.
    Britto CJ; Brady V; Lee S; Dela Cruz CS
    Clin Chest Med; 2017 Mar; 38(1):87-96. PubMed ID: 28159164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of throat microbial flora in smokers with or without COPD.
    Diao W; Shen N; Du Y; Qian K; He B
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1933-1946. PubMed ID: 28740374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper and lower respiratory tract microbiota in horses: bacterial communities associated with health and mild asthma (inflammatory airway disease) and effects of dexamethasone.
    Bond SL; Timsit E; Workentine M; Alexander T; Léguillette R
    BMC Microbiol; 2017 Aug; 17(1):184. PubMed ID: 28835202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lung Microbiome and Airway Disease.
    Lynch SV
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2(Suppl 5):S462-S465. PubMed ID: 28005424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
    Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
    Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.